Microlyte® Matrix

Next Generation Wound Care

Microlyte® Matrix is a uniquely one-of-a-kind antimicrobial synthetic polymeric matrix used in the management of wounds.  The fully synthetic multi-layer sheet supplies a functional and biocompatible matrix that absorbs moisture to maintain moist healing environment, while the ultra-low amounts of metallic and ionic silver provides broad spectrum antimicrobial benefit and prevents microbial colonization in the matrix. 

As Microlyte® Matrix is placed onto the wound it transforms and contours to the underlying wound bed and contains a powerful and broad-spectrum antimicrobial  benefit without cytotoxicity and maintains a physiologically moist microenvironment.1,2,3,4,10,11

Try Microlyte® Matrix


Item #       GTIN # Size and Configuration
ML0505    00850019162103 5×5 sq. cm sheet
ML1010    00850019162110 10×10 sq. cm sheet


HCPCS Product Code: A2005 – Microlyte Matrix, per sq cm.


bioresorbable_icon.svg - Microlyte<sup>®</sup> Matrix – Wounds

Biocompatible Matrix

Fully synthetic biocompatible polymer matrix provides consistent handling.2

contour_icon.svg - Microlyte<sup>®</sup> Matrix – Wounds

Conforms to Wound Bed

Absorbs wound fluid and conforms to the wound bed serving as a functional and biocompatible matrix.2,4

transparent_icon.svg - Microlyte<sup>®</sup> Matrix – Wounds

Transparent & Synthetic

Allows for clear view of wound bed, isn’t of human or animal origin, and holds a long room-temperature shelf life.1

toxicity_icon.svg - Microlyte<sup>®</sup> Matrix – Wounds

Non-Toxic & 99.99% Effective

99.99% effective against a broad spectrum of wound related microbes.3

Microlyte® Matrix

Clinically Proven

Published clinical data in the November 2020 edition of WOUNDS journal shows the clinical results of using Microlyte® Matrix for chronic wounds. Thirty-two patients with various chronic wounds were evaluated.  All wounds were non-healing for a median of 39 weeks (range, 3-137 weeks).

At 3 weeks:  79% closure in responsive DFU patients. 60% closure in responsive venous stasis ulcers. 72% of all wounds had significantly improved healing with an average wound area reduction of 66%.

At 12 weeks:  91% of wounds either healed completely or improved significantly with an average wound area reduction of 73%. 

The application of Microlyte® Matrix was safe and well tolerated, and it facilitated improvements in healing of a majority of the complex chronic wounds studied.8